English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Neuronal effects of a natural pharmaceutical product for control of stress: a randomized, placebo-controlled, double-blind, cross-over fMRI trial

Walter, M., Chand, T., Teckentrup, V., Kühnel, A., Fensky, L., Alizadeh, S., et al. (2017). Neuronal effects of a natural pharmaceutical product for control of stress: a randomized, placebo-controlled, double-blind, cross-over fMRI trial. In 51. Kongress für Allgemeinmedizin und Familienmedizin der Deutschen Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM 2017).

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0000-C552-5 Version Permalink: http://hdl.handle.net/21.11116/0000-0000-C553-4
Genre: Meeting Abstract

Files

show Files

Locators

show
hide
Locator:
Link (Any fulltext)
Description:
-

Creators

show
hide
 Creators:
Walter, M1, 2, Author              
Chand, T1, 2, Author              
Teckentrup, V, Author
Kühnel, A, Author
Fensky, L, Author
Alizadeh, S1, 2, Author              
Jamalabadi, H, Author
Schultz, M, Author
Fan, Y, Author
Affiliations:
1Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497794              
2Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497796              

Content

show
hide
Free keywords: -
 Abstract: Background: Neurexan®, a natural pharmaceutical product, is composed of passionflower, oats, coffee and zinc valerianate. It has been investigated in acute stressed patients and patients with insomnia. Stress initiates changes in functional connectivity (FC) between amygdala and cortical regions. The functional integrity can be assessed via amygdala-centered resting-state (rs) FC. Amygdala is involved in developing fear and emotions. Amygdala reactivity to negative stimuli associates with stress regulation and can be assessed with the Hariri paradigm. Previous studies reported associations between ongoing variability in Autonomous Nervous System (ANS) tone measured by heart rate variability (HRV) and stress-induced changes in dACC and amygdala FC. Question: Does Neurexan® affect emotional brain response to stress? Method: Thirty-nine healthy male subjects participated in a double-blind, randomized, placebo-controlled, within-subject cross-over fMRI study assessing Neurexan® effects at 3 Tesla. In each session, an 11 min rs-measurement was performed at baseline, after single dose of Neurexan® or placebo and after exposure to psychosocial stress. The emotional Hariri paradigm was measured after intake of verum or placebo. HRV was recorded continuously during the sessions. Data were preprocessed and analyzed in SPM12 and DPABI. Results: Significant effect of Neurexan® was found on rs-FC between left centromedial amygdala and cortical regions. In the Hariri task, paired t-test showed a drug effect in left amygdala, with stronger activations in placebo than Neurexan® condition. Comparing Neurexan® and placebo groups, Neurexan® improved variability in ANS tone in both conditions, prior and after psychosocial stress, compared to baseline. Discussion: We saw a beneficial effect of Neurexan® on stress-induced brain function.

Details

show
hide
Language(s):
 Dates: 2017-09-22
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: DOI: 10.3205/17degam144
BibTex Citekey: WalterCTKFAJSF2017
 Degree: -

Event

show
hide
Title: 51. Kongress für Allgemeinmedizin und Familienmedizin der Deutschen Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM 2017)
Place of Event: Düsseldorf, Germany
Start-/End Date: -

Legal Case

show

Project information

show

Source 1

show
hide
Title: 51. Kongress für Allgemeinmedizin und Familienmedizin der Deutschen Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM 2017)
Source Genre: Proceedings
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: - Sequence Number: - Start / End Page: - Identifier: -